What they were paid
ROCKET PHARMACEUTICALS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | — | $154,897 | — | — | $154,897 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ROCKET PHARMACEUTICALS, INC. DEF 14A filed April 6, 2026, accession 0001140361-26-013335, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the ROCKET PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Carsten Boess | Independent Director | $158,025 |
| David Southwell | Independent Director | $138,650 |
| Elisabeth Björk | Independent Director | $117,400 |
| Fady Malik | Independent Director | $132,400 |
| Gaurav Shah | Director | $0 |
| Mikael Dolsten | Director | $382,394 |
| Peter Fong | Independent Director | $191,385 |
| Piratip Pratumsuwan | Independent Director | $627,714 |
| Roderick Wong | Director | $134,898 |
The full ROCKET PHARMACEUTICALS compensation record
free company briefThis page is one director within ROCKET PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat